Inari Medical Reports Fourth Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Inari Medical, Inc. (NARI) Misses Q4 EPS by 9c, Beats on Revenue
February 28, 2024 4:29 PM ESTInari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of ($0.08), $0.09 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $132.1 million versus the consensus estimate of $131.76 million.
For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.
... More